Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Status epilepticus: recent trends and prospects

A V Delgado-Escueta1, C Y Fong

  • 1Comprehensive Epilepsy Program, UCLA School of Medicine, USA.

Neurologia (Barcelona, Spain)
|February 21, 1998
PubMed
Summary

Prompt termination of convulsive status epilepticus within 60 minutes is crucial to prevent brain damage. This review examines current treatments and proposes an updated protocol for status epilepticus management based on seizure type and EEG.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The efficacy of vagus nerve stimulation for epilepsy in Malaysia.

The Medical journal of Malaysia·2024
Same author

Cutaneous involvement in chronic lymphocytic leukaemia.

British journal of haematology·2024
Same author

Microstructural abnormalities found in uncinate fasciculus and superior cerebellar tracts in children with global developmental delay: a feasibility study.

Clinical radiology·2019
Same author

Apparent diffusion coefficient in differentiation between malignant and benign breast masses: does size matter?

Clinical radiology·2015
Same author

Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia.

Leukemia·2013
Same author

Tranexamic acid without prophylactic factor replacement for prevention of bleeding in hereditary bleeding disorder patients undergoing endoscopy: a pilot study.

Haemophilia : the official journal of the World Federation of Hemophilia·2013

Area of Science:

  • Neurology
  • Epilepsy Research
  • Clinical Neurophysiology

Background:

  • Convulsive status epilepticus (CSE) can lead to chronic memory impairment due to brain damage.
  • Timely intervention within 60 minutes is critical for effective treatment and minimizing neurological deficits.
  • Existing first-line agent regimens include diazepam plus phenytoin, lorazepam, barbiturates, and phenytoin alone.

Purpose of the Study:

  • To discuss the mechanisms of brain damage in chronic memory impairment related to CSE.
  • To review current first-line treatment options for status epilepticus.
  • To present an updated, evidence-based protocol for managing status epilepticus.

Main Methods:

  • Review of available literature on status epilepticus treatment regimens.
  • Analysis of drug properties for ideal status epilepticus management.
  • Development of a new protocol integrating seizure type and electroencephalogram (EEG) characteristics.

Main Results:

  • Intravenous lorazepam is recommended as a first-line agent for primary tonic-clonic/clonic-tonic-clonic status with specific EEG findings (8 Hz diffuse sharp rhythms or 2-5 Hz spike/multispike wave complexes).
  • Lorazepam is also suitable for complex partial status and absence status.
  • Phenytoin infusion or rectal sodium valproate are options for tonic status and atypical absence status.
  • Refractory convulsive status epilepticus requires termination with barbiturate or fluothane general anesthesia.

Conclusions:

  • An updated protocol stratifies status epilepticus treatment based on clinical presentation and EEG patterns.
  • Early and appropriate intervention is key to preventing long-term neurological consequences.
  • The protocol guides the selection of first-line agents and escalation strategies for refractory cases.

Related Experiment Videos